Multicentric prospettive study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: Interim analysis of INNOVATE study.

被引：0
|
作者：
Gardini, Andrea Casadei
Marisi, Giorgia
Dadduzio, Vincenzo
Faloppi, Luca
Ielasi, Luca
Vivaldi, Caterina
Rizzato, Mario Domenico
Fornaro, Lorenzo
Lonardi, Sara
Gramantieri, Laura
Pecora, Irene
Foschi, Giuseppe Francesco
Silvestris, Nicola
Fornari, Francesca
Orsi, Giulia
Rovesti, Giulia
Santini, Daniele
Zagonel, Vittorina
Cascinu, Stefano
Scartozzi, Mario
机构：
[1] IRCCS, IRST, Meldola, Italy
[2] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy
[3] IRCCS, Ist Oncol Veneto, Padua, Italy
[4] Univ Cagliari, Univ Hosp, Dept Med Oncol, Cagliari, Italy
[5] UNIBO, Bologna, Italy
[6] Azienda Osped Univ Pisana, Pisa, Italy
[7] IVO Veneto, Padua, Italy
[8] IRCCS, IOV, Med Oncol Unit 1, Dept Clin & Expt Oncol, Padua, Italy
[9] St Orsola Marcello Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy
[10] Canc Inst Giovanni Paolo II, Med Oncol Unit, Bari, Italy
[11] UNIMORE, Modena, Italy
[12] Campus Biomed Univ Rome, Dept Med Oncol, Rome, Italy
[13] Univ Hosp Modena, Modena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4075
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
    Luca Faloppi
    Marco Puzzoni
    Andrea Casadei Gardini
    Nicola Silvestris
    Gianluca Masi
    Giorgia Marisi
    Caterina Vivaldi
    Cosmo Damiano Gadaleta
    Pina Ziranu
    Maristella Bianconi
    Cristian Loretelli
    Laura Demurtas
    Eleonora Lai
    Riccardo Giampieri
    Eva Galizia
    Paola Ulivi
    Nicola Battelli
    Alfredo Falcone
    Stefano Cascinu
    Mario Scartozzi
    Targeted Oncology, 2020, 15 : 801 - 802
  • [32] Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
    Luca Faloppi
    Marco Puzzoni
    Andrea Casadei Gardini
    Nicola Silvestris
    Gianluca Masi
    Giorgia Marisi
    Caterina Vivaldi
    Cosmo Damiano Gadaleta
    Pina Ziranu
    Maristella Bianconi
    Cristian Loretelli
    Laura Demurtas
    Eleonora Lai
    Riccardo Giampieri
    Eva Galizia
    Paola Ulivi
    Nicola Battelli
    Alfredo Falcone
    Stefano Cascinu
    Mario Scartozzi
    Targeted Oncology, 2020, 15 : 115 - 126
  • [33] First subgroup interim analysis of German patients from a global non-interventional study in metastatic renal cell carcinoma patients treated with sorafenib - the PREDICT study
    Jaeger, D.
    Brehmer, B.
    Stauch, K.
    Yu, J.
    ONKOLOGIE, 2010, 33 : 106 - 106
  • [34] A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
    Marasco, Giovanni
    Poggioli, Francesco
    Colecchia, Antonio
    Cabibbo, Giuseppe
    Pelizzaro, Filippo
    Giannini, Edoardo Giovanni
    Marinelli, Sara
    Rapaccini, Gian Ludovico
    Caturelli, Eugenio
    Di Marco, Mariella
    Biasini, Elisabetta
    Marra, Fabio
    Morisco, Filomena
    Foschi, Francesco Giuseppe
    Zoli, Marco
    Gasbarrini, Antonio
    Svegliati Baroni, Gianluca
    Masotto, Alberto
    Sacco, Rodolfo
    Raimondo, Giovanni
    Azzaroli, Francesco
    Mega, Andrea
    Vidili, Gianpaolo
    Brunetto, Maurizia Rossana
    Nardone, Gerardo
    Alemanni, Luigina Vanessa
    Dajti, Elton
    Ravaioli, Federico
    Festi, Davide
    Trevisani, Franco
    CANCERS, 2021, 13 (11)
  • [35] Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study
    Yen, Clarence
    Sharma, Rohini
    Rimassa, Lorenza
    Arizumi, Tadaaki
    Bettinger, Dominik
    Choo, Huay Yee
    Pressiani, Tiziana
    Burlone, Michela E.
    Pirisi, Mario
    Giordano, Laura
    Abdulrahman, Anisa
    Kudo, Masatoshi
    Thimme, Robert
    Park, Joong Won
    Pinato, David James
    LIVER CANCER, 2017, 6 (04) : 313 - 324
  • [36] Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
    Debnarayan Dutta
    Tushar Tatineni
    Sreenija Yarlagadda
    Ajinkya Gupte
    Sruthi K. Reddy
    Ram Madhavan
    Haridas Nair
    Ajay Sasidharan
    Rajesh Kannan
    Shibu G. Pottayil
    Raghavendra Holla
    Surendran Sudhindran
    Indian Journal of Gastroenterology, 2021, 40 : 389 - 401
  • [37] Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
    Dutta, Debnarayan
    Tatineni, Tushar
    Yarlagadda, Sreenija
    Gupte, Ajinkya
    Reddy, Sruthi K.
    Madhavan, Ram
    Nair, Haridas
    Sasidharan, Ajay
    Kannan, Rajesh
    Pottayil, Shibu G.
    Holla, Raghavendra
    Sudhindran, Surendran
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2021, 40 (04) : 389 - 401
  • [38] Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
    Sheng-Long Ye
    Jiamei Yang
    Ping Bie
    Shuijun Zhang
    Xiaoping Chen
    Fengyong Liu
    Luming Liu
    Jie Zhou
    Kefeng Dou
    Chunyi Hao
    Guoliang Shao
    Qiang Xia
    Yajin Chen
    Jijin Yang
    Xiaxing Deng
    Yunpeng Liu
    Yunfei Yuan
    Zhiren Fu
    Keiko Nakajima
    Zhengguang Lv
    BMC Cancer, 18
  • [39] Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
    Ye, Sheng-Long
    Yang, Jiamei
    Bie, Ping
    Zhang, Shuijun
    Chen, Xiaoping
    Liu, Fengyong
    Liu, Luming
    Zhou, Jie
    Dou, Kefeng
    Hao, Chunyi
    Shao, Guoliang
    Xia, Qiang
    Chen, Yajin
    Yang, Jijin
    Deng, Xiaxing
    Liu, Yunpeng
    Yuan, Yunfei
    Fu, Zhiren
    Nakajima, Keiko
    Lv, Zhengguang
    BMC CANCER, 2018, 18
  • [40] International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
    Diaz-Gonzalez, Alvaro
    Sanduzzi-Zamparelli, Marco
    Fonseca, Leonardo G.
    Di Costanzo, Giovan G.
    Alves, Rogerio
    Iavarone, Massimo
    Leal, Cassia
    Sacco, Rodolfo
    Matilla, Ana M.
    Hernandez-Guerra, Manuel
    Aballay Soteras, Gabriel
    Woerns, Marcus-Alexander
    Pinter, Matthias
    Varela, Maria
    Ladekarl, Morten
    Chagas, Aline L.
    Minguez, Beatriz
    Arenas, Juan, I
    Granito, Alessandro
    Sanchez-Torrijos, Yolanda
    Rojas, Angela
    Rodriguez de Lope, Carlos
    Alvares-da-Silva, Mario R.
    Pascual, Sonia
    Rimassa, Lorenza
    Lledo, Jose L.
    Huertas, Carlos
    Sangro, Bruno
    Giannini, Edoardo G.
    Delgado, Manuel
    Vergara, Mercedes
    Perello, Christie
    Lue, Alberto
    Sala, Margarita
    Gallego, Adolfo
    Coll, Susanna
    Hernaez, Tania
    Pinero, Federico
    Pereira, Gustavo
    Franca, Alex
    Marin, Juan
    Anders, Margarita
    Mello, Vivianne
    Lozano, Mar
    Nault, Jean C.
    Menendez, Josemaria
    Garcia Juarez, Ignacio
    Bruix, Jordi
    Reig, Maria
    LIVER INTERNATIONAL, 2020, 40 (06) : 1467 - 1476
12345